CHRISTIE BOONE: Open Payments
NPI 1073585162 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 44 payments from 19 companies in 2025. Trend: 2023 $928 · 2024 $1,064 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| Amgen Inc. | 5 | $85 |
| ABBVIE INC. | 3 | $71 |
| Corcept Therapeutics | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Novo Nordisk Inc | 3 | $53 |
| PFIZER INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $36 |
Products named: Korlym, LEQVIO, Kerendia, UBRELVY, Cologuard Collection Kit, MOUNJARO, NEXLETOL, JARDIANCE.
Industry payments across KY — which companies pay providers there.
